<DOC>
<DOCNO>
EP-0014531
</DOCNO>
<TEXT>
<DATE>
19800820
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/365 A61K-31/165 A61P-25/00 A61K-31/167 A61P-25/04 A61K-20060101S <main>A61K-31/365</main> B65B-20060101S A61P-29/00 
</IPC-CLASSIFICATIONS>
<TITLE>
pharmaceutical compositions containing paracetamol.
</TITLE>
<APPLICANT>
beecham group plcgb<sep>beecham group plc<sep>beecham group plcbeecham house, great west roadbrentford, middlesex tw8 9bdgb<sep>beecham group plc  <sep>
</APPLICANT>
<INVENTOR>
davis adrian francis<sep>davis, adrian francis<sep>davis, adrian francis124 park roadhounslow middlesexgb<sep>davis, adrian francis<sep>davis, adrian francis124 park roadhounslow middlesexgb<sep>
</INVENTOR>
<ABSTRACT>
the acute liver toxicity effects of paracetamol are reduced  by co-formulating with ascorbic acid derivatives (ascorbate  anion bioprecursors) which produce high liver concentrations  of ascorbate anion after oral administration of the co-Â­ formulation.  a suitable ascorbate anion bioprecursor is  ascorbyl 6-palmitate.  
</ABSTRACT>
</TEXT>
</DOC>
